1. Tirzepatide treatment significantly reduced body weight and fat composition in obese patients while improving cardiometabolic risk factors and physical ...
Click here to read this study in the New England Journal of Medicine.
1. This randomized controlled trial demonstrated that in adult type 2 diabetes patients on daily basal insulin, adding tirzepatide significantly ...
1. From baseline to 52 weeks, tirzepatide resulted in a greater reduction in mean HbA1c levels compared to insulin glargine. ...
1. Tirzepatide was superior to placebo with regard to changes in HbA1c, serum glucose, body weight loss, and proportion of ...
